PLN-74809

· Pliant Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for PLN-74809, covering 2022-11-17 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC) [Phase 2]

See pricing